Adipokines, tumor necrosis factor and its receptors in female patients with systemic lupus erythematosus

Lupus

Volumn 26, Issue 1, 2017, Pages 10-16

  Santos, F M M ^a   Telles, R W ^a   Lanna, C C D ^a   Teixeira, A L ^a   Miranda, A S ^a   Rocha, N P ^a   Ribeiro, A L ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

Author keywords

Adipokines; systemic lupus erythematosus; tumor necrosis factor; tumor necrosis factor receptors

Indexed keywords

ADIPOCYTOKINE; ADIPONECTIN; ANTIMALARIAL AGENT; AZATHIOPRINE; CORTICOSTEROID; CYCLOPHOSPHAMIDE; LEPTIN; METHOTREXATE; RESISTIN; SOLUBLE TUMOR NECROSIS FACTOR ALPHA RECEPTOR 1; SOLUBLE TUMOR NECROSIS FACTOR ALPHA RECEPTOR 2; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; UNCLASSIFIED DRUG; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2;

ADULT; ARTHRITIS; ARTICLE; CROSS-SECTIONAL STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; DISEASE DURATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LUPUS ERYTHEMATOSUS; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYSTEMIC LUPUS ERYTHEMATOSUS; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; SEVERITY OF ILLNESS INDEX;

ADIPOKINES; ADULT; ANTIMALARIALS; CROSS-SECTIONAL STUDIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LEPTIN; LUPUS ERYTHEMATOSUS, SYSTEMIC; LUPUS NEPHRITIS; MIDDLE AGED; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; RESISTIN; SEVERITY OF ILLNESS INDEX; TUMOR NECROSIS FACTOR-ALPHA;

EID: 85006087911     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203316646463     Document Type: Article

References (47)

1. Su DL, Lu ZM, Shen MN, Li X, Sun LY,. Roles of pro- and anti-inflammatory cytokines in the pathogenesis of SLE. J Biomed Biotechnol 2012; 2012: 347141-347141.
2. Postal M, Appenzeller S,. The role of Tumor Necrosis Factor-alpha (TNF-alpha) in the pathogenesis of systemic lupus erythematosus. Cytokine 2011; 56: 537-543.
3. Heilig B, Fiehn C, Brockhaus M, Gallati H, Pezzutto A, Hunstein W,. Evaluation of soluble tumor necrosis factor (TNF) receptors and TNF receptor antibodies in patients with systemic lupus erythematodes, progressive systemic sclerosis, and mixed connective tissue disease. J Clin Immunol 1993; 13: 321-328.
4. Aderka D, Wysenbeek A, Engelmann H, et al. Correlation between serum levels of soluble tumor necrosis factor receptor and disease activity in systemic lupus erythematosus. Arthritis Rheum 1993; 36: 1111-1120.
5. Aderka D, Engelmann H, Maor Y, Brakebusch C, Wallach D,. Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors. J Exp Med 1992; 175: 323-329.
6. Davas EM, Tsirogianni A, Kappou I, Karamitsos D, Economidou I, Dantis PC,. Serum IL-6, TNFalpha, p55 srTNFalpha, p75srTNFalpha, srIL-2alpha levels and disease activity in systemic lupus erythematosus. Clin Rheumatol 1999; 18: 17-22.
7. Gabay C, Cakir N, Moral F, et al. Circulating levels of tumor necrosis factor soluble receptors in systemic lupus erythematosus are significantly higher than in other rheumatic diseases and correlate with disease activity. J Rheumatol 1997; 24: 303-308.
8. Zhu L, Yang X, Ji Y, et al. Up-regulated renal expression of TNF-alpha signalling adapter proteins in lupus glomerulonephritis. Lupus 2009; 18: 116-127.
9. Toussirot E, Streit G, Wendling D,. The contribution of adipose tissue and adipokines to inflammation in joint diseases. Curr Med Chem 2007; 14: 1095-1100.
10. Krysiak R, Handzlik-Orlik G, Okopien B,. The role of adipokines in connective tissue diseases. Eur J Nutr 2012; 51: 513-528.
11. Wislowska M, Rok M, Stepien K, Kuklo-Kowalska A,. Serum leptin in systemic lupus erythematosus. Rheumatol Int 2008; 28: 467-473.
12. Ahima RS, Prabakaran D, Mantzoros C, et al. Role of leptin in the neuroendocrine response to fasting. Nature 1996; 382: 250-252.
13. Otero M, Lago R, Gomez R, et al. Towards a pro-inflammatory and immunomodulatory emerging role of leptin. Rheumatology (Oxford) 2006; 45: 944-950.
14. Almehed K, d'Elia HF, Bokarewa M, Carlsten H,. Role of resistin as a marker of inflammation in systemic lupus erythematosus. Arthritis Res Ther 2008; 10: R15-R15.
15. Vadacca M, Zardi EM, Margiotta D, et al. Leptin, adiponectin and vascular stiffness parameters in women with systemic lupus erythematosus. Intern Emerg Med 2013; 8: 705-712.
16. Mraz M, Haluzik M,. The role of adipose tissue immune cells in obesity and low-grade inflammation. J Endocrinol 2014; 222: R113-R127.
17. Vielma SA, Klein RL, Levingston CA, Young MR,. Adipocytes as immune regulatory cells. Int Immunopharmacol 2013; 16: 224-231.
18. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982; 25: 1271-1277.
19. Hochberg MC,. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725-1725.
20. Uribe AG, Vila LM, McGwin G Jr, Sanchez ML, Reveille JD, Alarcon GS,. The Systemic Lupus Activity Measure-revised, the Mexican Systemic Lupus Erythematosus Disease Activity Index (SLEDAI), and a modified SLEDAI-2K are adequate instruments to measure disease activity in systemic lupus erythematosus. J Rheumatol 2004; 31: 1934-1940.
21. Gladman DD, Ibanez D, Urowitz MB,. Systemic lupus erythematosus disease activity index 2000. J Rheumatol 2002; 29: 288-291.
22. Gladman D, Ginzler E, Goldsmith C, et al. The development and initial validation of the Systemic Lupus International Collaborating Clinics/American College of Rheumatology damage index for systemic lupus erythematosus. Arthritis Rheum 1996; 39: 363-369.
23. Petri M, Buyon J, Kim M,. Classification and definition of major flares in SLE clinical trials. Lupus 1999; 8: 685-691.
24. World Health Organization. Obesity: Preventing and managing the global epidemic. Report of WHO consultation, Geneva: World Health Organization, 1997, pp. 276-276.
25. Aringer M, Smolen JS,. SLE-complex cytokine effects in a complex autoimmune disease: Tumor necrosis factor in systemic lupus erythematosus. Arthritis Res Ther 2003; 5: 172-177.
26. Zampieri S, Alaibac M, Iaccarino L, et al. Tumour necrosis factor alpha is expressed in refractory skin lesions from patients with subacute cutaneous lupus erythematosus. Ann Rheum Dis 2006; 65: 545-548.
27. Mahmoud RA, El-Gendi HI, Ahmed HH,. Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus. Clin Biochem 2005; 38: 134-141.
28. Takemura T, Yoshioka K, Murakami K, et al. Cellular localization of inflammatory cytokines in human glomerulonephritis. Virchows Arch 1994; 424: 459-464.
29. Mosca M, Tani C, Filice ME, et al. TNF-alpha inhibitors in systemic lupus erythematosus. A case report and a systematic literature review. Mod Rheumatol 2015; 25: 642-645.
30. Sacre K, Criswell LA, McCune JM,. Hydroxychloroquine is associated with impaired interferon-alpha and tumor necrosis factor-alpha production by plasmacytoid dendritic cells in systemic lupus erythematosus. Arthritis Res Ther 2012; 14: R155-R155.
31. McCarthy EM, Smith S, Lee RZ, et al. The association of cytokines with disease activity and damage scores in systemic lupus erythematosus patients. Rheumatology (Oxford) 2014; 53: 1586-1594.
32. Chung CP, Long AG, Solus JF, et al. Adipocytokines in systemic lupus erythematosus: Relationship to inflammation, insulin resistance and coronary atherosclerosis. Lupus 2009; 18: 799-806.
33. Baker JF, Morales M, Qatanani M, et al. Resistin levels in lupus and associations with disease-specific measures, insulin resistance, and coronary calcification. J Rheumatol 2011; 38: 2369-2375.
34. De Sanctis JB, Zabaleta M, Bianco NE, Garmendia JV, Rivas L,. Serum adipokine levels in patients with systemic lupus erythematosus. Autoimmunity 2009; 42: 272-274.
35. Garcia-Gonzalez A, Gonzalez-Lopez L, Valera-Gonzalez IC, et al. Serum leptin levels in women with systemic lupus erythematosus. Rheumatol Int 2002; 22: 138-141.
36. McMahon M, Skaggs BJ, Sahakian L, et al. High plasma leptin levels confer increased risk of atherosclerosis in women with systemic lupus erythematosus, and are associated with inflammatory oxidised lipids. Ann Rheum Dis 2011; 70: 1619-1624.
37. Song H, Chan J, Rovin BH,. Induction of chemokine expression by adiponectin in vitro is isoform dependent. Transl Res 2009; 154: 18-26.
38. Loghman M, Haghighi A, Broumand B, et al. Association between urinary adiponectin level and renal involvement in systemic lupus erythematous. Int J Rheum Dis 2014. Epub ahead of print. DOI: 10.1111/1756-185X.12284.
39. Rovin BH, Song H, Hebert LA, et al. Plasma, urine, and renal expression of adiponectin in human systemic lupus erythematosus. Kidney Int 2005; 68: 1825-1833.
40. Mills KT, Hamm LL, Alper AB, et al. Circulating adipocytokines and chronic kidney disease. PLoS One 2013; 8: e76902-e76902.
41. Kawamura R, Doi Y, Osawa H, et al. Circulating resistin is increased with decreasing renal function in a general Japanese population: The Hisayama Study. Nephrol Dial Transplant 2010; 25: 3236-3240.
42. Axelsson J, Bergsten A, Qureshi AR, et al. Elevated resistin levels in chronic kidney disease are associated with decreased glomerular filtration rate and inflammation, but not with insulin resistance. Kidney Int 2006; 69: 596-604.
43. Karmiris K, Koutroubakis IE, Xidakis C, Polychronaki M, Voudouri T, Kouroumalis EA,. Circulating levels of leptin, adiponectin, resistin, and ghrelin in inflammatory bowel disease. Inflamm Bowel Dis 2006; 12: 100-105.
44. Caza TN, Talaber G, Perl A,. Metabolic regulation of organelle homeostasis in lupus T cells. Clin Immunol 2012; 144: 200-213.
45. Lord GM, Matarese G, Howard JK, Baker RJ, Bloom SR, Lechler RI,. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 1998; 394: 897-901.
46. Bokarewa M, Nagaev I, Dahlberg L, Smith U, Tarkowski A,. Resistin, an adipokine with potent proinflammatory properties. J Immunol 2005; 174: 5789-5795.
47. Senolt L, Housa D, Vernerova Z, et al. Resistin in rheumatoid arthritis synovial tissue, synovial fluid and serum. Ann Rheum Dis 2007; 66: 458-463.